Leading Lap has redesigned the trocar’s tip to prevent puncturing or injuring organs upon insertion. Georgia Tech biomedical engineering students Hailey Avis, Cameron Bennett, Will Kamnick and Katherine Strickland make up this team for the Fall 2019 Capstone Design Expo.
Thanks to GCMI’s Capstone Day, the team was able to use their device in a highly clinical, practical situation. “Being able to test the device in a cadaveric setting thanks to GCMI was the best opportunity we could have been afforded at this stage,” Lando said.
Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…
GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…
In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…
Yet another edition of the SEMDA Medtech Conference has come and gone. The 2019 edition saw colleagues from 26 states attend and significant diversity among the PitchRounds companies who hailed from AL, AR, GA, FL, KY, MS, NC, SC, TN, TX and VA. Every year, SEMDA is the place to connect with the entirety of…
Last August a multi-disciplinary team contributed to Georgia’s first surgery to place 3D-printed tracheal splints in a pediatric patient. As first reported by GT Research Horizons, “The patient who received the groundbreaking surgery is a 7-month-old boy battling both congenital heart disease and tracheo-bronchomalacia, a condition that causes severe life-threatening airway obstruction. During his six-month…
Our take on the SEMDA 2019 Medtech Conference sponsorship value proposition. GCMI’s mission is to accelerate the pathway to commercialization of innovative medical products. To accomplish this, we need to meet the innovators, the large strategics, investors and consultant partners who all need to work in concert to improve lives and reduce overall healthcare spending.…
Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…
Last year, Ares Health Systems became the first digital health company to enter GCMI’s accelerator, accessing our digital health commercial development expertise and health system relationships to further validate the value of Ares’ MPower care management platform and commence market penetration. “Our confidence in our value proposition has increased since we’ve last talked,” says Ares…